Read More Pharma Industry News Moleculin’s $9.3m raise adds 49.5m potential shares after MIRACLE update Moleculin’s 37% MIRACLE remission signal is followed by a $9.3 million offering, heavy warrant dilution and a 59% stock drop. bySoujanya RaviAugust 2, 2026